# Are YAP and TAZ valid prognostic signatures for NSCLC patients?

**Authors:** Antonios N. Gargalionis, Kostas A. Papavassiliou, Athanasios G. Papavassiliou

PMC · DOI: 10.1111/jcmm.17992 · Journal of Cellular and Molecular Medicine · 2023-10-11

## Full-text entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, TAFAZZIN (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 6901] {aka BTHS, CMD3A, EFE, EFE2, G4.5, LVNCX}, AREG (amphiregulin) [NCBI Gene 374] {aka AR, AREGB, CRDGF, SDGF}
- **Diseases:** TNM (MESH:D009362), lung squamous cell carcinoma (MESH:D002294), lung adenocarcinoma (MESH:D000077192), cancer (MESH:D009369), NSCLC (MESH:D002289), SCLC (MESH:D055752), node and metastasis (MESH:D008207), Lung carcinomas (MESH:D008175)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10826437/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC10826437/full.md

---
Source: https://tomesphere.com/paper/PMC10826437